Who Paid My Doc
Brian Waldron
Neuromusculoskeletal Medicine & OMM New York, NY Doctor of Osteopathy
NPI 1093785651 CMS profile 185965
61 Broadway, Ste 910, New York, NY 10006
General payments
$2,192
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Brian Waldron of New York, NY is reported in the CMS Open Payments database as having received $2,192 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 87th percentile of Neuromusculoskeletal Medicine & OMM profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $2,192 | 6 |
Beside peers
- Brian Waldron
- Neuromusculoskeletal Medicine & OMM median
- Middle half of Neuromusculoskeletal Medicine & OMM
- National median
In program year 2025, general payments to Brian Waldron were reported at $0. Among 217 Neuromusculoskeletal Medicine & OMM profiles paid that year, the median was $119 and the middle half received between $36 and $380.
Show as a table
| Year | Brian Waldron | Neuromusculoskeletal Medicine & OMM median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,192 | $92 | $27–$283 | $163 |
| 2020 | $0 | $85 | $20–$411 | $114 |
| 2021 | $0 | $120 | $32–$548 | $132 |
| 2022 | $0 | $96 | $32–$518 | $149 |
| 2023 | $0 | $92 | $33–$328 | $160 |
| 2024 | $0 | $122 | $35–$378 | $164 |
| 2025 | $0 | $119 | $36–$380 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
11
Drug cost
$35
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Meloxicam | Generic | 11 | $35 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 526 Part D prescribers listed as Osteopathic Manipulative Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$151,616
Medicare patients
176
Services billed
2,049
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 69% | |
| High blood pressure | 54% | |
| Osteoporosis | 35% | |
| Ischemic heart disease | 26% | |
| Cancer | 26% | |
| Diabetes | 18% | |
| Depression | 18% | |
| Chronic kidney disease | 9% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neuromusculoskeletal Medicine & OMM in New York
Mehri Songhorian
Neuromusculoskeletal Medicine & OMM · Elmhurst, NY
Clair Cascella
Neuromusculoskeletal Medicine & OMM · New Hyde Park, NY
Richard Chmielewski
Neuromusculoskeletal Medicine & OMM · New Hartford, NY
Kerin Hausknecht
Neuromusculoskeletal Medicine & OMM · Lynbrook, NY
Mohammed Islam
Neuromusculoskeletal Medicine & OMM · Elmhurst, NY
Michael Florek
Neuromusculoskeletal Medicine & OMM · New York, NY
Related records
Neuromusculoskeletal Medicine & OMM in New York
Practitioners in the same specialty and state, ranked by reported value.
All Neuromusculoskeletal Medicine & OMM
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.